ICD-10-CM Code C44.399

Other specified malignant neoplasm of skin of other parts of face

Version 2020 Billable Code Neoplasm Malignant Primary

Valid for Submission

C44.399 is a billable code used to specify a medical diagnosis of other specified malignant neoplasm of skin of other parts of face. The code is valid for the year 2020 for the submission of HIPAA-covered transactions.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: brow specified type NEC or cheek external specified type NEC or chin specified type NEC or eyebrow specified type NEC or forehead (skin) specified type NEC .

ICD-10:C44.399
Short Description:Oth malignant neoplasm of skin of other parts of face
Long Description:Other specified malignant neoplasm of skin of other parts of face

Diagnostic Related Groups

The ICD-10 code C44.399 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 606 - MINOR SKIN DISORDERS WITH MCC
  • 607 - MINOR SKIN DISORDERS WITHOUT MCC

Convert C44.399 to ICD-9

  • 173.39 - Mal neo skn face NEC/NOS (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Melanoma and other malignant neoplasms of skin (C43-C44)
      • Other and unspecified malignant neoplasm of skin (C44)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code C44.399 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»brow
  »specified type NEC
C44.399
»cheek
  »external
    »specified type NEC
C44.399
»chin
  »specified type NEC
C44.399
»eyebrow
  »specified type NEC
C44.399
»forehead (skin)
  »specified type NEC
C44.399

Information for Patients


Skin Cancer

Skin cancer is the most common form of cancer in the United States. The two most common types are basal cell cancer and squamous cell cancer. They usually form on the head, face, neck, hands, and arms. Another type of skin cancer, melanoma, is more dangerous but less common.

Anyone can get skin cancer, but it is more common in people who

  • Spend a lot of time in the sun or have been sunburned
  • Have light-colored skin, hair and eyes
  • Have a family member with skin cancer
  • Are over age 50

You should have your doctor check any suspicious skin markings and any changes in the way your skin looks. Treatment is more likely to work well when cancer is found early. If not treated, some types of skin cancer cells can spread to other tissues and organs. Treatments include surgery, radiation therapy, chemotherapy, photodynamic therapy (PDT), and biologic therapy. PDT uses a drug and a type of laser light to kill cancer cells. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute


[Learn More]